Elimination of lohexol, a Low Osmolar Nonionic Contrast Medium, by Hemodialysis in Patients with Chronic Renal Failure
Authors:
- M. SvalandMSM. Svaland
- P. FauchaldPFP. Fauchald
- J.å. JakobsenJJJ.å. Jakobsen
- F. KolmannskogFKF. Kolmannskog
- K.J. BergKBK.J. Berg
- 1 January 1990
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 56 (1) , 81-85
Abstract
The dialyzability of iohexol was examined in patients with chronic renal failure on long-term hemodialysis treatment. Eight patients had iohexol (Omnipaque® 240 or 350 mg I/ml) injected in doses between 98 and 1,493 mg I/kg body weight (BW) 25 h (mean time) before start of hemodialysis. Dialysance of iohexol was 81 ± 15 ml/min (mean ± SD) compared to 120 ± 16.8 ml/min for creatinine. Elimination half-life for iohexol during hemodialysis was 3.9 ± 1.1 h while plasma clearance was 64 ± 17 ml/min. The distribution volume calculated (0.25 ± 0.05 liters/kg BW) confirms previous observations with distribution in the extracellular fluid only. Before the start of hemodialysis 36 ± 28% of the dose injected was eliminated, indicating some extrarenal elimination. After 4 h of hemodialysis 72 ± 11% of the dose was removed.Keywords
This publication has 4 references indexed in Scilit:
- Pharmacokinetics of Iothalamate in Endstage Renal DiseaseThe Journal of Clinical Pharmacology, 1988
- PHARMACOKINETIC STUDY OF IOXAGLATE, A LOW OSMOLALITY CONTRAST-MEDIUM, IN PATIENTS WITH RENAL-FAILURE1986
- Pharmacokinetics of Low- and High-Dose Intravenous Diatrizoate Contrast Media AdministrationInvestigative Radiology, 1984
- The Extra-renal Excretion of Diatrizoate in Renal FailureBritish Journal of Radiology, 1966